Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Seferian, X. Jaïs, D. Montani, S. Günther, D. Natali, L. Savale, F. Parent, D. S. O‘Callaghan, O. Sitbon, M. Humbert, G. Simonneau (Clamart, France). Chronic thromboembolic pulmonary hypertension associated with Klippel Trenaunay syndrome: A retrospective series of 5 patients. Eur Respir J 2011; 38: Suppl. 55, 2351

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Pulmonary manifestations of antiphospholipid syndrome: A retrospective analysis of 67 patients Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Abernethy syndrome: A rare cause of pulmonary hypertension Source: International Congress 2018 – Paediatric bronchology Year: 2018 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Pulmonary hypertension in patients with chronic myeloproliferative disorders Source: Eur Respir J 2010; 35: 1396-1406 Year: 2010 Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Autoimmune polyglandular syndrome and pulmonary arterial hypertension Source: Eur Respir J 2006; 27: 657 Year: 2006 Chronic thromboembolic pulmonary hypertension: a distinct disease entity Source: Eur Respir Rev 2015; 24: 246-252 Year: 2015 The prevalence of restless leg syndrome in chronic obstructive pulmonary diseases(COPD) patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Sarcoidosis associated pulmonary hypertension (SAPH) in the Netherlands Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Pulmonary arterial hypertension (PAH) in primary Sjögren‘s syndrome: report of 9 cases Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Pulmonary arterial hypertension related with congenital heart disease (PAH r-CHD): a retrospective study of 21 patients Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 Challenging cases in PH Source: Eur Respir Rev 2008; 17: 19-23 Year: 2007 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016